Jupiter Topco LLC Invests $872,000 in DENTSPLY SIRONA Inc. $XRAY

Jupiter Topco LLC bought a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 82,200 shares of the medical instruments supplier’s stock, valued at approximately $872,000.

Several other large investors also recently bought and sold shares of XRAY. Hsbc Holdings PLC purchased a new stake in DENTSPLY SIRONA during the 2nd quarter worth about $464,000. Canada Pension Plan Investment Board acquired a new position in shares of DENTSPLY SIRONA during the second quarter worth about $271,000. Legal & General Group Plc purchased a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $3,249,000. The Manufacturers Life Insurance Company purchased a new stake in shares of DENTSPLY SIRONA during the second quarter worth approximately $1,956,000. Finally, Paradigm Capital Management Inc. NY acquired a new stake in DENTSPLY SIRONA in the second quarter valued at approximately $39,775,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Brian P. Mckeon bought 10,000 shares of the stock in a transaction dated Friday, June 12th. The shares were acquired at an average cost of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the transaction, the director owned 10,000 shares in the company, valued at approximately $101,200. The trade was a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Brian T. Gladden purchased 9,985 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, June 15th. The stock was acquired at an average price of $10.02 per share, with a total value of $100,049.70. Following the transaction, the director owned 61,849 shares in the company, valued at $619,726.98. The trade was a 19.25% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought 35,160 shares of company stock worth $351,179 in the last quarter. 0.46% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Barclays boosted their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a report on Monday, August 24th. Piper Sandler lifted their price objective on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 29th. BMO Capital Markets reiterated a “market perform” rating and set a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, August 7th. Weiss Ratings restated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. Finally, Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a report on Monday, August 10th. Three analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $13.54.

DENTSPLY SIRONA Trading Down 0.4%

NASDAQ XRAY opened at $11.38 on Friday. The firm’s fifty day moving average price is $12.16 and its 200 day moving average price is $11.67. DENTSPLY SIRONA Inc. has a 12 month low of $9.40 and a 12 month high of $14.86. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. The company has a market capitalization of $2.27 billion, a price-to-earnings ratio of -4.14, a price-to-earnings-growth ratio of 1.45 and a beta of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. The firm had revenue of $898.00 million during the quarter, compared to analysts’ expectations of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. DENTSPLY SIRONA’s quarterly revenue was down 4.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current fiscal year.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.